✦ LIBER ✦

P-572 Phase I–II trial of TLK286 (telcyta), carboplatin (C), and paclitaxel(P) as first-line treatment for advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Seguist, L.; Fidias, P.; Temel, J.; Kennedy, E.; Ostler, P.; Rabin, M.; Huberman, M.; Keck, J.; Brown, G.; Lynch, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-550 Phase 1–2 dose-ranging trial of TL

✍ Papadimitrakopoulou, V.; Edelman, M.; Zinner, R.; Blumenschein, G.; Jones, S.; W 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

191 Phase II trial of paclitaxel and car

✍ Schütte, W.; Bork, I.; Schädlich, St.; Meyer, M.; Blankenburg, Th. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Preoperative treatment with paclitaxel a

✍ De Candis, D; Stani, S.C; Bidoli, P; Potepan, P; Bedini, V.A; Cataldo, I; Michet 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A phase I/randomized phase II, non-compa

✍ Roger B. Cohen; Corey J. Langer; George Rajan Simon; Peter David Eisenberg; John 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 387 KB

Phase III trial of paclitaxel (P), carbo

✍ Socinski, MA; Sandler, AB; Petit, RG; Steagall, A; Hanover, CK; Natale, RB; Mill 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 212 KB

P-251 Randomized phase II trial of weekl

✍ Socinski, Mark A.; Hensing, Thomas A.; Escudero, Miluska; Tynan, Maureen; Baggst 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 340 KB